Endocrinology

Her2+

Questions discussed in this category

Do you give bisphosphonates after completing adjuvant anti-HER2 therapy and chemotherapy for HER2+ breast cancer to reduce the risk of recurrence?

2 Answers available

Papers discussed in this category

Lancet,

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-07-20

Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).

Curr Treat Options Oncol, 2019 Mar 14

Role of Bisphosphonates in Breast Cancer Therapy.

Related Topics in Endocrinology